ACT-1004-1239
| Code | Size | Price |
|---|
| TAR-T39665-5mg | 5mg | £502.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
ACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC 50 value of 3.2 nM.
CAS:
2178049-58-4
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Richard-Bildstein S, et al. Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239. J Med Chem. 2020 Dec 24;63(24):15864-15882.